Literature DB >> 27542118

Expression of tissue factor and forkhead box transcription factor O-1 in a rat model for chronic thromboembolic pulmonary hypertension.

Chaosheng Deng1, Dawen Wu2, Minxia Yang2, Yunfei Chen2, Caiyun Wang2, Zhanghua Zhong2, Ningfang Lian2, Hua Chen2, Shuang Wu2.   

Abstract

Few reports have examined tissue factor (TF) and forkhead box transcription factor O-1 (FoxO1) expression in chronic thromboembolic pulmonary hypertension (CTEPH) animal models. To investigate the role of TF and FoxO1 and their interactions during CTEPH pathogenesis in a rat model. Autologous blood clots were repeatedly injected into the pulmonary arteries through right jugular vein to induce a rat model of CTEPH. Hemodynamic parameters, histopathology, and TF and FoxO1expression levels were detected. The mean pulmonary arterial pressure (mPAP), pulmonary vascular resistance and vessel wall area/total area (WA/TA) ratio in the experiment group increased significantly than sham group (P < 0.05). The cardiac output in the 1-, 2-, and 4-week groups decreased significantly (P < 0.05) when compared to sham group. TF mRNA expression levels in the experiment group increased significantly than sham group (P < 0.05). FoxO1 mRNA and protein expression levels were lower in the experiment group than sham group (P < 0.05). The mPAP had a positive correlation with WA/TA ratio (r = 0.45, P = 0.01). TF mRNA expression had a positive correlation with WA/TA ratio (r = 0.374, P = 0.035) and a positive correlation with mPAP (r = 0.48, P= 0.005). FoxO1 mRNA expression had a negative correlation trend with the WA/TA ratio (r = -0.297, P = 0.099) and a negative correlation trend with mPAP (r = -0.34, P = 0.057). TF mRNA expression had a negative correlation with FoxO1 mRNA expression (r = -0.62, P < 0.001). A rat model of CTEPH can be successfully established by the injection of autologous blood clots into the pulmonary artery. TF and FoxO1 may play a key role in vascular remodeling during CTEPH pathogenesis.

Entities:  

Keywords:  Animal model; FoxO1; Pulmonary hypertension; Pulmonary thromboembolism; Tissue factor

Mesh:

Substances:

Year:  2016        PMID: 27542118     DOI: 10.1007/s11239-016-1413-9

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  32 in total

1.  The role of carrier number on the procoagulant activity of tissue factor in blood and plasma.

Authors:  G W Tormoen; S Rugonyi; A Gruber; O J T McCarty
Journal:  Phys Biol       Date:  2011-11-02       Impact factor: 2.583

2.  Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension.

Authors:  Rajkumar Savai; Hamza M Al-Tamari; Daniel Sedding; Baktybek Kojonazarov; Christian Muecke; Rebecca Teske; Mario R Capecchi; Norbert Weissmann; Friedrich Grimminger; Werner Seeger; Ralph Theo Schermuly; Soni Savai Pullamsetti
Journal:  Nat Med       Date:  2014-10-26       Impact factor: 53.440

3.  Plasma levels of microparticle-associated tissue factor activity in patients with clinically suspected pulmonary embolism.

Authors:  P Garcia Rodriguez; H C J Eikenboom; M E T Tesselaar; M V Huisman; M Nijkeuter; S Osanto; R M Bertina
Journal:  Thromb Res       Date:  2010-08-12       Impact factor: 3.944

Review 4.  Autophagy in vascular disease.

Authors:  Stefan W Ryter; Seon-Jin Lee; Akaya Smith; Augustine M K Choi
Journal:  Proc Am Thorac Soc       Date:  2010-02

5.  Development and comparison of a minimally-invasive model of autologous clot pulmonary embolism in Sprague-Dawley and Copenhagen rats.

Authors:  Michael S Runyon; Michael A Gellar; Nina Sanapareddy; Jeffrey A Kline; John A Watts
Journal:  Thromb J       Date:  2010-02-11

6.  Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data.

Authors:  M Riedel; V Stanek; J Widimsky; I Prerovsky
Journal:  Chest       Date:  1982-02       Impact factor: 9.410

7.  Expression of tissue factor in rabbit pulmonary artery in an acute pulmonary embolism model.

Authors:  Jing-Xia Zhang; Yong-Li Chen; Yu-Ling Zhou; Qian-Yu Guo; Xian-Pei Wang
Journal:  World J Emerg Med       Date:  2014

8.  Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease.

Authors:  Vijender Reddy Vaidyula; Gerard J Criner; Carla Grabianowski; A Koneti Rao
Journal:  Thromb Res       Date:  2009-01-21       Impact factor: 3.944

9.  Diagnostic utility of NT-proBNP and ANP in a canine model of chronic embolic pulmonary hypertension.

Authors:  Yasutomo Hori; Tsuyoshi Uchide; Ryuta Saitoh; Daisuke Thoei; Makiko Uchida; Kazuki Yoshioka; Seishiro Chikazawa; Fumio Hoshi
Journal:  Vet J       Date:  2012-05-10       Impact factor: 2.688

10.  Tissue factor as a proinflammatory agent.

Authors:  Maria I Bokarewa; James H Morrissey; Andrej Tarkowski
Journal:  Arthritis Res       Date:  2002-01-10
View more
  4 in total

Review 1.  Chronic Thromboembolic Pulmonary Hypertension: the Bench.

Authors:  George A Alba; Deepak Atri; Sriranjani Darbha; Inderjit Singh; Victor F Tapson; Michael I Lewis; Hyung J Chun; Yen-Rei Yu; Bradley A Maron; Sudarshan Rajagopal
Journal:  Curr Cardiol Rep       Date:  2021-08-19       Impact factor: 2.931

2.  Model of Chronic Thromboembolic Pulmonary Hypertension in Rats Caused by Repeated Intravenous Administration of Partially Biodegradable Sodium Alginate Microspheres.

Authors:  Andrei A Karpov; Nikita A Anikin; Aleksandra M Mihailova; Sergey S Smirnov; Dariya D Vaulina; Leonid A Shilenko; Dmitry Yu Ivkin; Alexei Y Bagrov; Olga M Moiseeva; Michael M Galagudza
Journal:  Int J Mol Sci       Date:  2021-01-24       Impact factor: 5.923

Review 3.  Rodent models of pulmonary embolism and chronic thromboembolic pulmonary hypertension.

Authors:  Andrei A Karpov; Dariya D Vaulina; Sergey S Smirnov; Olga M Moiseeva; Michael M Galagudza
Journal:  Heliyon       Date:  2022-02-24

4.  Implication of proliferation gene biomarkers in pulmonary hypertension.

Authors:  Yi Yan; Rong Jiang; Ping Yuan; Li Wen; Xiao-Bin Pang; Zhi-Cheng Jing; Yang-Yang He; Zhi-Yan Han
Journal:  Animal Model Exp Med       Date:  2021-11-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.